AAAAAA

   
Results: 1-25 | 26-49
Results: 1-25/49

Authors: YOSHIYAMA Y YAZAKI T BEAUCHAMP D KANKE M
Citation: Y. Yoshiyama et al., PROTECTIVE EFFECT OF CEFTRIAXONE AGAINST THE NEPHROTOXICITY OF ISEPAMICIN ADMINISTERED ONCE-DAILY IN RATS, Biological & pharmaceutical bulletin, 21(5), 1998, pp. 520-523

Authors: WASHINGTON K CHIAPPORI A HAMILTON K SHYR Y BLANKE C JOHNSON D SAWYERS J BEAUCHAMP D
Citation: K. Washington et al., EXPRESSION OF BETA-CATENIN, ALPHA-CATENIN, AND E-CADHERIN IN BARRETTS-ESOPHAGUS AND ESOPHAGEAL ADENOCARCINOMAS, Modern pathology, 11(9), 1998, pp. 805-813

Authors: LAROCHELLE B FLAMAND L GOURDE P BEAUCHAMP D GOSSELIN J
Citation: B. Larochelle et al., EPSTEIN-BARR-VIRUS INFECTS AND INDUCES APOPTOSIS IN HUMAN NEUTROPHILS, Blood, 92(1), 1998, pp. 291-299

Authors: BEAUCHAMP D BERGERON MG
Citation: D. Beauchamp et Mg. Bergeron, PHARMACOLOGICAL PRINCIPLES OF PYELONEPHRITIS TREATMENT - DISTRIBUTION, EFFICIENCY AND RENAL TOXICITY OF ANTIBIOTICS, MS. Medecine sciences, 13(8-9), 1997, pp. 942-951

Authors: LUAN J SHATTUCKBRANDT R HAGHNEGAHDAR H OWEN JD STRIETER R BURDICK M NIRODI C BEAUCHAMP D NEWSOM K RICHMOND A
Citation: J. Luan et al., MECHANISM AND BIOLOGICAL SIGNIFICANCE OF CONSTITUTIVE EXPRESSION OF MGSA GRO CHEMOKINES IN MALIGNANT-MELANOMA TUMOR PROGRESSION/, Journal of leukocyte biology, 62(5), 1997, pp. 588-597

Authors: BEAUCHAMP D GUIMONT C GRENIER L LEBRUN M TARDIF D GOURDE P BERGERON MG THIBAULT L LABRECQUE G
Citation: D. Beauchamp et al., TIME-RESTRICTED FEEDING SCHEDULES MODIFY TEMPORAL VARIATION OF GENTAMICIN EXPERIMENTAL NEPHROTOXICITY, Antimicrobial agents and chemotherapy, 41(7), 1997, pp. 1468-1474

Authors: BEAUCHAMP D LAURENT G GRENIER L GOURDE P ZANEN J HEUSONSTIENNON JA BERGERON MG
Citation: D. Beauchamp et al., ATTENUATION OF GENTAMICIN-INDUCED NEPHROTOXICITY IN RATS BY FLEROXACIN, Antimicrobial agents and chemotherapy, 41(6), 1997, pp. 1237-1245

Authors: TURCOTTE A SIMARD M MORIN NJ BEAUCHAMP D BERGERON MG
Citation: A. Turcotte et al., DIFFERENTIAL DISTRIBUTIONS IN TISSUES AND EFFICACIES OF AZTREONAM ANDCEFTAZIDIME AND IN-VIVO BACTERIAL MORPHOLOGICAL-CHANGES FOLLOWING TREATMENT, Antimicrobial agents and chemotherapy, 41(2), 1997, pp. 401-409

Authors: OMAR RF HARVIE P GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN AND FOSCARNET EACH GIVENALONE OR IN COMBINATION IN THE MURINE AIDS MODEL, Toxicology and applied pharmacology, 143(1), 1997, pp. 140-151

Authors: BEAUCHAMP D HARDY E
Citation: D. Beauchamp et E. Hardy, THE STELLAR POPULATIONS OF SPIRAL DISKS .1. A NEW OBSERVATIONAL APPROACH - DESCRIPTION OF THE TECHNIQUE AND SPECTRAL GRADIENTS FOR THE INTER-ARM REGIONS OF NGC-4321 (M100), The Astronomical journal, 113(5), 1997, pp. 1666-1677

Authors: HARVIE P OMAR RF DUSSERRE N DESORMEAUX A GOURDE P TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., ANTIVIRAL EFFICACY AND TOXICITY OF RIBAVIRIN IN MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, Journal of acquired immune deficiency syndromes and human retrovirology, 12(5), 1996, pp. 451-461

Authors: LIN LS GRENIER L LEBRUN M BERGERON MG THIBAULT L LABRECQUE G BEAUCHAMP D
Citation: Ls. Lin et al., DAY-NIGHT TREATMENT DIFFERENCE OF TOBRAMYCIN SERUM AND INTRARENAL DRUG DISTRIBUTION AND NEPHROTOXICITY IN RATS - EFFECTS OF FASTING, Chronobiology international, 13(2), 1996, pp. 113-121

Authors: BEAUCHAMP D COLLIN P GRENIER L LEBRUN M COUTURE M THIBAULT L LABRECQUE G BERGERON MG
Citation: D. Beauchamp et al., EFFECTS OF FASTING ON TEMPORAL VARIATIONS IN NEPHROTOXICITY OF GENTAMICIN IN RATS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 670-676

Authors: YOSHIYAMA Y GRENIER L GOURDE P SIMARD M LIN LS MORIN NJ BERGERON MG LABRECQUE G BEAUCHAMP D
Citation: Y. Yoshiyama et al., TEMPORAL VARIATION IN NEPHROTOXICITY OF LOW-DOSES OF ISEPAMICIN IN RATS, Antimicrobial agents and chemotherapy, 40(3), 1996, pp. 802-806

Authors: HARVIE P DESORMEAUX A BERGERON MC TREMBLAY M BEAUCHAMP D POULIN L BERGERON MG
Citation: P. Harvie et al., COMPARATIVE PHARMACOKINETICS, DISTRIBUTIONS IN TISSUE, AND INTERACTIONS WITH BLOOD PROTEINS OF CONVENTIONAL AND STERICALLY STABILIZED LIPOSOMES CONTAINING 2',3'-DIDEOXYINOSINE, Antimicrobial agents and chemotherapy, 40(1), 1996, pp. 225-229

Authors: OMAR RF GOURDE P DESORMEAUX A TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: Rf. Omar et al., IN-VIVO TOXICITY OF FOSCARNET AND ZIDOVUDINE GIVEN ALONE OR IN COMBINATION, Toxicology and applied pharmacology, 139(2), 1996, pp. 324-332

Authors: LEBRUN M GRENIER L GOURDE P BERGERON MG LABRECQUE G BEAUCHAMP D
Citation: M. Lebrun et al., NEPHROTOXICITY OF AMPHOTERICIN-B IN RATS - EFFECTS OF THE TIME OF ADMINISTRATION, Life sciences, 58(11), 1996, pp. 869-876

Authors: HARVIE P OMAR RF DUSSERRE N LANSAC N DESORMEAUX A GOURDE P SIMARD M TREMBLAY M BEAUCHAMP D BERGERON MG
Citation: P. Harvie et al., RIBAVIRIN POTENTIATES THE EFFICACY AND TOXICITY OF 2',3'-DIDEOXYINOSINE IN THE MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME MODEL, The Journal of pharmacology and experimental therapeutics, 279(2), 1996, pp. 1009-1017

Authors: EID P WONG PTT LACELLE S BERGERON MG BEAUCHAMP D CARRIER D
Citation: P. Eid et al., EFFECT OF DAPTOMYCIN ON THE BAROTROPIC BEHAVIOR OF DIOLEOYLPHOSPHATIDYLGLYCEROL - AN INFRARED SPECTROSCOPIC INVESTIGATION, Chemistry and physics of lipids, 83(2), 1996, pp. 131-140

Authors: DELOCHE G HANNEQUIN D CARLOMAGNO S AGNIEL A DORDAIN M PASQUIER F PELLAT J DENIS P DESI M BEAUCHAMP D METZLUTZ MN CESARO P SERON X
Citation: G. Deloche et al., CALCULATION AND NUMBER PROCESSING IN MILD ALZHEIMERS-DISEASE, Neuropsychology, development, and cognition. Section A, Journal of clinical and experimental neuropsychology, 17(4), 1995, pp. 634-639

Authors: MAKABIPANZU B LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG
Citation: B. Makabipanzu et al., UPTAKE AND BINDING OF LIPOSOMAL 2',3'-DIDEOXYCYTIDINE BY RAW-264.7 CELLS - A 3-STEP PROCESS, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 227-235

Authors: LIN LS GRENIER L GUIMONT C LEBRUN M LABRECQUE G BERGERON MG BEAUCHAMP D
Citation: Ls. Lin et al., CIRCADIAN VARIATION IN THE INTRACORTICAL ACCUMULATION KINETICS OF TOBRAMYCIN IN CONSCIOUS RATS, Chronobiology international, 12(3), 1995, pp. 188-194

Authors: DUSSERRE N LESSARD C BEAUCHAMP D DESORMEAUX A POULIN L TREMBLAY M BERGERON MG
Citation: N. Dusserre et al., LIPOSOMAL ENCAPSULATION DELIVERS FOSCARNET (PFA) TO SITES OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND IMPROVES ITS PHARMACOKINETICS, Journal of cellular biochemistry, 1995, pp. 177-177

Authors: BEAUCHAMP D LABRECQUE G BERGERON MG
Citation: D. Beauchamp et al., CAN THE NEPHROTOXICITY OF AMINOGLYCOSIDES BE REDUCED, Pathologie et biologie, 43(9), 1995, pp. 779-787

Authors: DUSSERRE N LESSARD C PAQUETTE N PERRON S POULIN L TREMBLAY M BEAUCHAMP D DESORMEAUX A BERGERON MG
Citation: N. Dusserre et al., ENCAPSULATION OF FOSCARNET IN LIPOSOMES MODIFIES DRUG INTRACELLULAR ACCUMULATION, IN-VITRO ANTI-HIV-1 ACTIVITY, TISSUE DISTRIBUTION AND PHARMACOKINETICS, AIDS, 9(8), 1995, pp. 833-841
Risultati: 1-25 | 26-49